Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
15.50
-0.35 (-2.21%)
Jun 9, 2026, 3:04 PM CST

SHE:000739 Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, SHE:000739 stock has a consensus rating of "Strong Buy" and an average price target of ¥20.07. The average 1-year stock price forecast is 29.48% higher than the current stock price, while the lowest is ¥19.00 (+22.58%) and the highest is ¥21.00 (+35.48%).

Price Target: ¥20.07 (+29.48%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price¥19.00¥20.07¥20.20¥21.00
Change+22.58%+29.48%+30.32%+35.48%

Analyst Ratings

The average analyst rating for SHE:000739 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingAug '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy443233
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total665455

Financial Forecast

Revenue This Year
10.45B
from 9.78B
Increased by 6.78%
Revenue Next Year
11.34B
from 10.45B
Increased by 8.60%
EPS This Year
0.89
from 0.67
Increased by 33.43%
EPS Next Year
1.03
from 0.89
Increased by 15.73%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJan 1, 2022Jan 1, 2023Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.94B10.54B11.47B12.02B9.78B10.45B
Revenue Growth
13.49%17.92%8.81%4.77%-18.62%6.78%
Gross Profit
2.36B2.47B2.85B2.80B2.49B2.89B
Gross Margin
26.43%23.42%24.86%23.26%25.41%27.70%
Operating Income
959.39M906.80M1.08B1.01B877.83M1.26B
Net Income
955.55M989.17M1.06B1.03B890.68M1.21B
EPS
----0.670.89
EPS Growth
-----21.19%33.43%
Forward PE
23.0323.0323.0323.0323.0317.42
Dividend / Share
0.290.300.320.360.590.32
Dividend Growth
-4.21%6.70%12.35%64.68%-45.43%
Free Cash Flow
554.62M1.37B-28.58M504.46M672.82M703.00M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High11.0B
Avg10.4B
Low9.7B

Revenue Growth

Revenue Growth202620272028
High
12.0%
Avg
6.8%
Low
-1.3%

EPS Forecast

EPS202620272028
High-
Avg0.89
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
33.4%
Low-